Ahearn Matthew Fraser
Transaction: 06/15/2026
SELL
Change
-2,500
Price
$19.26
Filing
06/16/2026
Type
SELL
Shoulder Innovations, Inc.
SI • Medical - Specialties
$20.32
▼ -0.07 (-0.34%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 54%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$419.67M
Growth
-21.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.1Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$20.32
Change-0.34%
Shares Out20.65M
Market Cap$419.67M
Enterprise Value$326.14M
52W Range10.92 - 22.92
Beta-1.07
P/E-9.52
P/S7.79
P/B3.16
P/FCF-9.58
EV/Sales6.05
Price$20.32
Change-0.34%
Shares Out20.65M
Market Cap$419.67M
Enterprise Value$326.14M
52W Range10.92 - 22.92
Beta-1.07
P/E-9.52
P/S7.79
P/B3.16
P/FCF-9.58
EV/Sales6.05
EV/EBITDA-7.49
EV/FCF-7.45
Earnings Yield-10.50%
FCF Yield-10.44%
Dividend Yield0.00%
Gross Margin76.51%
Oper. Margin-55.58%
Profit Margin-85.29%
Debt/Eq0.10
Current Ratio-20.22
Quick Ratio-17.44
Revenue 5Y-20.98%
Target$23.50
Target Upside15.65%
Target Median$23.50
Target Range19.00 - 28.00
Volume386.43K
Avg Volume101.72K
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
21
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
32/100
Why this score▼
Manageable debt level · 0.1Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Price Target
2026-06-29
Low
$19.00
Mean
$19.00
Median
$19.00
High
$19.00
Insider Transactions
Recent executive and insider activity
Ahearn Matthew Fraser
Transaction: 06/12/2026
SELL
Change
-15,856
Price
$18.68
Filing
06/16/2026
Type
SELL
Ball Robert Joseph
Transaction: 04/30/2026
BUY
Change
+10,000
Price
$2.48
Filing
04/30/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Ahearn Matthew Fraser | SELL | -2,500 | $19.26 | 06/15/2026 | 06/16/2026 |
| Ahearn Matthew Fraser | SELL | -15,856 | $18.68 | 06/12/2026 | 06/16/2026 |
| Ball Robert Joseph | BUY | +10,000 | $2.48 | 04/30/2026 | 04/30/2026 |
| Ball Robert Joseph | SELL | -10,000 | $2.48 | 04/30/2026 | 04/30/2026 |
| Ahearn Matthew Fraser | SELL | -7,421 | $2.48 | 04/20/2026 | 04/21/2026 |
| Ahearn Matthew Fraser | BUY | +7,421 | $2.48 | 04/20/2026 | 04/21/2026 |
| Ball Robert Joseph | BUY | +2,200 | $15.18 | 03/13/2026 | 03/17/2026 |
| Buchholz Richard | BUY | +1,000 | $14.84 | 03/13/2026 | 03/17/2026 |
| BUCKMAN PAUL | SELL | -26,205 | $2.10 | 03/13/2026 | 03/17/2026 |
| BUCKMAN PAUL | BUY | +19,401 | $2.48 | 03/13/2026 | 03/17/2026 |
| Points Jeffrey S. | SELL | -13,264 | $2.48 | 03/13/2026 | 03/17/2026 |
| Points Jeffrey S. | BUY | +13,264 | $2.48 | 03/13/2026 | 03/17/2026 |
| Hykes Andrew | OTHER | 0 | Not reported | 02/26/2026 | 03/04/2026 |
| Ball Robert Joseph | BUY | +10,000 | $2.48 | 02/06/2026 | 02/10/2026 |
| Ball Robert Joseph | SELL | -2,062 | $2.10 | 02/06/2026 | 02/10/2026 |
| Ahearn Matthew Fraser | BUY | +88,450 | $14.16 | 01/30/2026 | 02/03/2026 |
| Ball Robert Joseph | BUY | +265,351 | $14.16 | 01/30/2026 | 02/03/2026 |
| Blue David Lawrence | BUY | +88,450 | $14.16 | 01/30/2026 | 02/03/2026 |
| Points Jeffrey S. | BUY | +126,357 | $14.16 | 01/30/2026 | 02/03/2026 |
| Ahearn Matthew Fraser | BUY | +477 | $12.16 | 12/31/2025 | 01/08/2026 |